Weight Loss, GLP-1 Therapy, and Hepatic Recovery Weight reduction itself is known to improve fatty liver disease, with studies showing that 5-10% body weight loss can reverse NAFLD in many patients
Tambin se ha observado que algunos metabolitos de la berberina podran estimular la secrecin de GLP-1 al reducir el estrs oxidativo y mejorar la funcin mitocondrial (Yang et al., 2024)
Vitamin D in Synaptic Plasticity, Cognitive Function, and Neuropsychiatric Illness
oral semaglutide demonstrated cardiovascular safety (non-inferiority) in the PIONEER 6 trial, but the addition of a stimulant medication may compromise this profile
Efeitos colaterais - Segundo o laboratrio, na pesquisa foram identificadas as seguintes reaes adversas: nuseas, diarreia, vmito, aumento da frequncia cardaca, arritmia, constipao e sensibilidade na pele
label notes these events were associated with weight reduction